Advances in chronic lymphocytic leukaemia: Expert panel discussion

1 Views
administrator
administrator
07/08/23

Visit http://www.ecancer.org for more.

Prof Gribben (Queen Mary University London, London, UK) chairs a discussion with Prof Hillmen (St James’ University Hospital, Leeds, UK), and Prof Mulligan (Royal North Shore Hospital, St Leonards, Australia) about the advances which have been made in chronic lymphocytic leukaemia (CLL) for ecancertv at EHA 2014. In particular, they discuss drugs such as ibrutinib and ofatumumab.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next